Rectal Microbicide Research Update – MTN 007 and MTN 017
There are exciting new developments in the rectal microbicide field. Please join IRMA and AVAC for a FREE global teleconference Thursday, March 15, 10am eastern, featuring Drs. Ian McGowan and Ross Cranston of the Microbicide Trials Network (MTN). Ian (co-principal investigator of the MTN) will share results from the MTN 007 trial – just released at CROI 2012.
Following Ian, Ross will discuss the upcoming MTN 017 trial – a Phase II safety and acceptability trial of the same gel studied in MTN 007 – which will have sites in 4 countries and will start later this year. MTN 017 is the first Phase II trial to be conducted in the rectal microbicide field, and will be the first time that trial sites from outside the U.S. are included.
For more info on MTN 007, click here.
For more info on MTN 017, click here.